Efficacy and Safety of Bone Wax Application at Different Time Points to Reduce Postoperative Blood Loss in Total Knee Arthroplasty: A Prospective Randomized Controlled Trial
- PMID: 39073003
- PMCID: PMC11456724
- DOI: 10.1111/os.14177
Efficacy and Safety of Bone Wax Application at Different Time Points to Reduce Postoperative Blood Loss in Total Knee Arthroplasty: A Prospective Randomized Controlled Trial
Abstract
Objective: In addition to the surface hemorrhage of cancellous bone after large-area osteotomy, the intramedullary hemorrhage after the reamed knee joint is also a major cause of postoperative bleeding after total knee arthroplasty (TKA). This study evaluated the efficacy and safety of bone wax application at different time points of prone hemorrhage to reduce perioperative blood loss.
Methods: From August 2023 to December 2023, 150 patients undergoing primary unilateral TKA were included in this prospective, randomized controlled trial, patients were randomly divided into three groups: group A, after autogenous osteotomy plug was used to fill the femoral medullary cavity, the residual space was sealed with bone wax and the exposed cancellous bone surface around the prosthesis was coated with bone wax after the prosthesis adhesion; group B, only the exposed cancellous bone surface around the prosthesis was coated with bone wax; and group C, no bone wax was used. The primary outcome was total perioperative blood loss. Secondary outcomes included occult blood loss, postoperative hemoglobin reduction, blood transfusion rate, lower limb diameter, and knee function, while length of hospital stay was recorded. Tertiary outcomes included the incidence of postoperative related adverse events.
Results: The total blood loss in group A (551.5 ± 224.5 mL) and group B (656.3 ± 267.7 mL) was significantly lower than that in group C (755.3 ± 248.3 ml, p < 0.001), and the total blood loss in group A was also lower than that in group B (p < 0.05). There were also significant differences in the reduction of hemoglobin level and hidden blood loss among the three groups (p < 0.05). However, there was no significant improvement in postoperative lower limb swelling, knee joint activity and hospitalization time; there was no significant difference in the incidence of complications such as thromboembolism.
Conclusion: The use of bone wax in TKA can safely and effectively reduce perioperative blood loss and hemoglobin drop rate, and multiple use at time points during the operation when blood loss is prone to occur can produce more significant hemostatic effect.
Keywords: Blood loss; Bone wax; Perioperative blood management; Safety; Total knee arthroplasty.
© 2024 The Author(s). Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Bone Wax Is Effective in Reducing Blood Loss After Total Knee Arthroplasty.J Arthroplasty. 2017 May;32(5):1483-1487. doi: 10.1016/j.arth.2016.12.028. Epub 2016 Dec 24. J Arthroplasty. 2017. PMID: 28089184 Clinical Trial.
-
Topical hemostatic procedures control blood loss in bilateral cemented single-stage total knee arthroplasty.J Orthop Sci. 2014 Nov;19(6):948-53. doi: 10.1007/s00776-014-0621-4. Epub 2014 Aug 27. J Orthop Sci. 2014. PMID: 25158897 Clinical Trial.
-
Use of bone wax reduces blood loss and transfusion rates after total knee arthroplasty.Knee. 2020 Oct;27(5):1411-1417. doi: 10.1016/j.knee.2020.07.074. Epub 2020 Aug 19. Knee. 2020. PMID: 33010755
-
Intramedullary sealing with a bone plug in total knee arthroplasty to reduce blood loss: a meta-analysis of randomized controlled trials.J Orthop Surg Res. 2019 Apr 8;14(1):96. doi: 10.1186/s13018-019-1141-x. J Orthop Surg Res. 2019. PMID: 30961640 Free PMC article. Review.
-
Sealing the Intramedullary Femoral Canal for Blood Loss in Total Knee Arthroplasty: A Meta-analysis of Randomized Controlled Trials.J Knee Surg. 2021 Jan;34(2):208-215. doi: 10.1055/s-0039-1694025. Epub 2019 Aug 8. J Knee Surg. 2021. PMID: 31394588
References
-
- Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Jt Surg Am. 2007;89(4):780–785. - PubMed
-
- Kolin DA, Sculco PK, Gonzalez Della Valle A, Rodriguez JA, Ast MP, Chalmers BP. Risk factors for blood transfusion and postoperative anaemia following total knee arthroplasty. Bone Jt J. 2023;105(10):1086–1093. - PubMed
-
- Frisch NB, Wessell NM, Charters MA, Yu S, Jeffries JJ, Silverton CD. Predictors and complications of blood transfusion in total hip and knee arthroplasty. J Arthroplasty. 2014;29(9):189–192. - PubMed
-
- Loftus TJ, Spratling L, Stone BA, Xiao L, Jacofsky DJ. A patient blood management program in prosthetic joint arthroplasty decreases blood use and improves outcomes. J Arthroplasty. 2016;31(1):11–14. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical